hypofractionated intensity-modulated radiation therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for hypofractionated intensity-modulated radiation therapy, covering 2019-04-12 to 2019-04-12. Get the full timeline:
Most recent: Clinical Trial Update: Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme [Phase 2]